BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4130286)

  • 1. The philosophy underlying the treatment of recurrent cancer of the head and neck.
    Sisson GA
    Otolaryngol Clin North Am; 1974 Feb; 7(1):153-61. PubMed ID: 4130286
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of recurrent head and neck cancer.
    Krespi YP; Wurster CF; Sisson GA
    Otolaryngol Clin North Am; 1985 Aug; 18(3):613-9. PubMed ID: 4047677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent tumors of the head and neck.
    Loré JM
    Laryngoscope; 1968 Sep; 78(9):1445-61. PubMed ID: 5693261
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent carcinoma of the head and neck: treatment strategies and survival analysis in a 20-year period.
    Eckardt A; Barth EL; Kokemueller H; Wegener G
    Oral Oncol; 2004 Apr; 40(4):427-32. PubMed ID: 14969822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative care for head and neck cancer patients in general practice.
    Ledeboer QC; Van der Velden LA; De Boer MF; Feenstra L; Pruyn JF
    Acta Otolaryngol; 2006 Sep; 126(9):975-80. PubMed ID: 16864497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurogenic tumours of the head and neck.
    Conley J
    J Otolaryngol Soc Aust; 1972; 3(3):362-8. PubMed ID: 4344318
    [No Abstract]   [Full Text] [Related]  

  • 7. The community approach to salvage therapy for advanced head and neck cancer.
    Adelstein DJ
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):52-7. PubMed ID: 7522350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET-CT in recurrent head neck cancers: a study to evaluate impact on patient management.
    Pantvaidya GH; Agarwal JP; Deshpande MS; Rangarajan V; Singh V; Kakade A; D'Cruz AK
    J Surg Oncol; 2009 Oct; 100(5):401-3. PubMed ID: 19235784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer.
    McLarnon C; Kulloo P; Mehanna H; Kelly C; Paleri V
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):345-52. PubMed ID: 20214516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalizing cancer care: updates on head and neck cancer.
    de Souza JA; Cohen EE
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local radiofrequency (RF) hyperthermia in the treatment of cancer: Edmonton experience.
    Jackson FI; Glazebrook GA; Usiskin SR; Kobayashi M
    J Can Assoc Radiol; 1984 Sep; 35(3):246-9. PubMed ID: 6209282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumor board recommendations on treatment outcome for locally advanced head and neck cancer.
    Nguyen NP; Vos P; Lee H; Borok TL; Karlsson U; Martinez T; Welsh J; Cohen D; Hamilton R; Nguyen N; Nguyen LM; Vinh-Hung V
    Oncology; 2008; 75(3-4):186-91. PubMed ID: 18841033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding role of the medical oncologist in the management of head and neck cancer.
    Choong N; Vokes E
    CA Cancer J Clin; 2008; 58(1):32-53. PubMed ID: 18096865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck cancer: recent advances and new standards of care.
    Forastiere AA; Trotti A; Pfister DG; Grandis JR
    J Clin Oncol; 2006 Jun; 24(17):2603-5. PubMed ID: 16763271
    [No Abstract]   [Full Text] [Related]  

  • 15. [Roundtable discussion -- tumor follow-up between the clinic and practice].
    Alberty J
    Laryngorhinootologie; 2008 Nov; 87(11):829-30. PubMed ID: 18982544
    [No Abstract]   [Full Text] [Related]  

  • 16. [Post-therapeutic follow-up of head and neck cancer].
    Barry B; de Raucourt D;
    Rev Prat; 2006 Oct; 56(15):1684-90. PubMed ID: 17137254
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines for treatment of recurrent or metastatic head and neck cancer.
    Parikh P; Patil V; Agarwal JP; Chaturvedi P; Vaidya A; Rathod S; Noronha V; Joshi A; Jamshed A; Bhattacharya GS; Gupta S; Desai C; Advani SH; Pai P; Laskar S; Ramesh A; Mohapatra PN; Vaid AK; Deshpande M; Ranade AA; Vora A; Baral R; Hussain MA; Rajan B; Dcruz AK; Prabhash K;
    Indian J Cancer; 2014; 51(2):89-94. PubMed ID: 25104184
    [No Abstract]   [Full Text] [Related]  

  • 18. Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review.
    Paleri V; Kelly CG
    Clin Otolaryngol; 2008 Aug; 33(4):331-7. PubMed ID: 18983342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck.
    Arnold DJ; Goodwin WJ; Weed DT; Civantos FJ
    Semin Radiat Oncol; 2004 Apr; 14(2):190-5. PubMed ID: 15095264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy.
    Argiris A; Li Y; Murphy BA; Langer CJ; Forastiere AA
    J Clin Oncol; 2004 Jan; 22(2):262-8. PubMed ID: 14722034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.